Lindenwold Advisors INC Invests $308,000 in Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Lindenwold Advisors INC has acquired a new position in Option Care Health, Inc., purchasing 8,826 shares valued at approximately $308,000 during the first quarter.
• Analysts have issued positive ratings for Option Care Health, with Barrington Research setting a target price of $38.00 and several firms upgrading their ratings for the stock.
• The company's recent earnings report showed revenue growth of 15.4%, with earnings per share reported at $0.41, exceeding analysts' expectations of $0.40.

Lindenwold Advisors INC bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 8,826 shares of the company's stock, valued at approximately $308,000.

Several other hedge funds and other institutional investors have also made changes to their positions in OPCH. Quadrant Capital Group LLC boosted its holdings in Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after buying an additional 1,099 shares in the last quarter. Public Employees Retirement System of Ohio lifted its holdings in shares of Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after purchasing an additional 332 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Option Care Health in the fourth quarter valued at about $47,000. Bessemer Group Inc. lifted its holdings in shares of Option Care Health by 62.3% in the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after purchasing an additional 599 shares in the last quarter. Finally, Wealthquest Corp purchased a new stake in shares of Option Care Health in the first quarter valued at about $66,000. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Stock Performance

Shares of OPCH stock traded up $0.18 during trading hours on Monday, reaching $28.44. The stock had a trading volume of 356,309 shares, compared to its average volume of 1,857,940. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The firm has a 50-day simple moving average of $31.04 and a 200-day simple moving average of $32.00. The firm has a market capitalization of $4.62 billion, a PE ratio of 22.76, a price-to-earnings-growth ratio of 1.79 and a beta of 0.79.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. Option Care Health's quarterly revenue was up 15.4% on a year-over-year basis. During the same quarter last year, the company earned $0.30 EPS. As a group, equities analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on OPCH. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities set a $38.00 price objective on shares of Option Care Health and gave the company a "market outperform" rating in a research report on Thursday. Barrington Research reissued an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research report on Thursday, July 10th. Finally, Citigroup reissued an "outperform" rating on shares of Option Care Health in a research report on Thursday. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $35.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.